Asthma/COPD Flashcards

1
Q

Little Johnny comes to your office complaining of recurrent episodes of wheezing, chest tightness, and coughing (often at night). What do you suspect?

A
  • asthma
  • chronic inflammation of the airways
  • variable airway obstruction that is usually completely reversible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Big Johnny comes to your office complaining of progressively feeling short of breath for the past year and half or so. He smoked a lot when he was younger. What do you suspect?

A
  • COPD
  • persistent airway limitation
  • enhanced chronic inflammatory response in the airways and lungs to noxious particles and gases
  • usually preventable and treatable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are differences in the airway smooth muscle, basement membrane, and degree of fibrosis when comparing asthma with COPD?

A
  • Asthma: airway SM is hypertrophic and basement membrane is thicker
  • COPD: more fibrosis is present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are two broad categories in use for therapy of COPD/asthma and name some classifications within each category

A
  • Bronchodilators (acting on airways): short and long acting inhaled β agonists, anticholinergics, and theophylline
  • Anti-inflammatory agents (acting on cells): inhaled corticosteroids, antileukotrienes, cromones, anti-immunoglobulin E
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the intracellular effects of β2 agonists?

A
  • stimulates Gs protein and increases adenylyl cyclase and cAMP, which raises PKA and induces bronchodilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the intracellular effects of theophylline?

A
  • prevents breakdown of cAMP, which raises PKA and induces bronchodilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

One of your patients has had well controlled asthma (with meditation) for years but has noticed that she tends to have a harder time breathing while exercising lately. You rule out any other cause besides her asthma - what can you prescribe her that she can use prior to beginning exercise to prevent these episodes? Tell me more about the drug.

A
  • shorting acting β2 agonist (probably albuterol, but can use terbutaline, meoproterenol, or pirbutol)
  • these drugs start working in 5 minutes and last about 6 hrs
  • SE: tremor, tachycardia, hyperglycemia, hypokalemia, hypomagnesaemia, prolonged QTc, lactic acidosis, paradoxical bronchospasm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

One of your patients is taking levalbuterol and claims that it isn’t working. What is unique about this drug? Upon further investigation, you realize that he’s taking the inhaler about 4 x’s/day. Why isn’t the drug working?

A
  • Levalbuterol, a short acting β2 agonist, is the R isomer of albuterol which is supposed to be associated with fewer side effects
  • however, clinically there is no significant difference between this drug and others in the class
  • Tolerance has developed due to a downregulation of β2 receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

You decide to prescribe your patient with COPD a long acting β2 agonist. What are your options?

A
  • salmeterol, formoterol, or indacaterol (COPD only)

- these last 12-24 hrs, and are highly lipid soluble which causes binding to a secondary exosite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

You decide to prescribe your patient with asthma a long acting β2 agonist. What must you remember to supplement with and why?

A
  • always use in combo with inhaled corticosteroids in the setting of asthma!
  • could be due to polymorphism in B-16 (arginine) locus of β receptor in some patients, increasing chance of death without steroid supplement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What receptor will anticholinergics ideally block, and accidental blockage of what receptor often causes side effects?

A
  • aiming for blockage of M3 receptor

- if drugs are non selective and inhibit M2, more ACh is released and smooth muscle constricts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some characteristics of tiotropium, the first line antimuscarinic agent for COPD?

A
  • long half life, with functional selectivity of M3 over M2
  • anti-inflammatory: reduces neutrophil migration and airway remodeling
  • decreases mucus production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is aclidinium bromide different than the older antimuscarinics?

A
  • metabolized in plasma, so short circulation half life –> less systemic/CNS side effects –> safe in higher doses
  • M3>M2 affinity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the mechanism of action of the methylxanthines (theophylline, theobromine, and caffeine)?

A
  • PDE 3, 4, and 5 inhibitor = bronchodilation
  • enhances histone deacetylation and suppresses inflammatory genes
  • improves contractility and reverses fatigue of diaphragm in COPD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the cornerstone treatment for persistent asthma?

A
  • corticosteroids! (ex. prednisone, dexamethasone, ciclesonide)
  • combining with β2 agonist has additive effect
  • also, there is little proof of benefit (in fact, COPD is a steroid resistant inflammation!) but highly used in COPD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What downstream effects do leukotriene inhibitors (such as zileuton, montelukast, pranlukast, and zafirukast) have?

A
  • less eosinophil recruitment
  • less mucus secretion
  • less plasma exudation
  • less bronchoconstriction
  • drug of choice in aspirin induced asthma
  • however, these drugs’ role in asthma are declining
17
Q

What monoclonal antibody is in use for patients with very severe asthma, and what is the MAB against?

A
  • omalizumab, an Anti-IgE
18
Q

What two asthma drugs are used exclusively in pediatrics patients and how do they work?

A
  • sodium cromoglycate and nedocromil sodium
  • prevent mast cell degranulation, prevent mediator release from macrophage and eosinophil
  • does this by altering the function of delayed chloride channel
19
Q

What up and coming techniques will be helpful in treating asthma and COPD in the future?

A
  • pharmacogenomics